Alex M. DePaoli

16.5k total citations · 9 hit papers
100 papers, 12.6k citations indexed

About

Alex M. DePaoli is a scholar working on Molecular Biology, Epidemiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Alex M. DePaoli has authored 100 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 44 papers in Epidemiology and 31 papers in Endocrine and Autonomic Systems. Recurrent topics in Alex M. DePaoli's work include Regulation of Appetite and Obesity (31 papers), Liver Disease Diagnosis and Treatment (24 papers) and Adipokines, Inflammation, and Metabolic Diseases (19 papers). Alex M. DePaoli is often cited by papers focused on Regulation of Appetite and Obesity (31 papers), Liver Disease Diagnosis and Treatment (24 papers) and Adipokines, Inflammation, and Metabolic Diseases (19 papers). Alex M. DePaoli collaborates with scholars based in United States, United Kingdom and Italy. Alex M. DePaoli's co-authors include Phillip Görden, Christos S. Mantzoros, Jean L. Chan, Elif A Oral, Johannes D. Veldhuis, Stephen O’Rahilly, Lei Ling, Elizabeth Lawrence, I. Sadaf Farooqi and Simeon I. Taylor and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Alex M. DePaoli

99 papers receiving 12.3k citations

Hit Papers

Beneficial effects of lep... 2002 2026 2010 2018 2002 2002 2002 2004 2004 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency
    2002 1.0k citations I. Sadaf Farooqi, Giuseppe Matarese et al. Journal of Clinical Investigation profile →
  2. Leptin-Replacement Therapy for Lipodystrophy
    2002 913 citations Elif A Oral, Alex M. DePaoli et al. New England Journal of Medicine profile →
  3. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency
    2002 854 citations I. Sadaf Farooqi, Giuseppe Matarese et al. Journal of Clinical Investigation profile →
  4. Recombinant Human Leptin in Women with Hypothalamic Amenorrhea
    2004 639 citations Corrine K. Welt, Jean L. Chan et al. New England Journal of Medicine profile →
  5. A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women
    2004 591 citations Robyn Murphy, Alex M. DePaoli et al. profile →
  6. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
    2002 581 citations Kitt Falk Petersen, Elif A Oral et al. Journal of Clinical Investigation profile →
  7. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
    2002 503 citations Kitt Falk Petersen, Elif A Oral et al. Journal of Clinical Investigation profile →
  8. NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
    2018 344 citations Stephen A. Harrison, James F. Trotter et al. profile →
  9. Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
    2020 218 citations Stephen A. Harrison, Guy Neff et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex M. DePaoli United States 58 4.7k 4.7k 4.3k 4.1k 2.1k 100 12.6k
Vishwa Deep Dixit United States 52 2.1k 0.4× 3.9k 0.8× 5.1k 1.2× 4.4k 1.1× 1.2k 0.5× 96 13.5k
Masatomo Mori Japan 48 2.6k 0.5× 1.4k 0.3× 1.8k 0.4× 2.0k 0.5× 1.4k 0.6× 263 8.3k
Márta Korbonits United Kingdom 65 4.2k 0.9× 2.9k 0.6× 3.3k 0.8× 3.8k 0.9× 2.5k 1.2× 422 15.5k
Michèle Guerre-Millo France 51 1.9k 0.4× 3.5k 0.7× 4.3k 1.0× 2.9k 0.7× 1.7k 0.8× 100 9.4k
Francesc Villarroya Spain 64 762 0.2× 4.6k 1.0× 8.2k 1.9× 6.2k 1.5× 996 0.5× 308 15.3k
Shuichi Okada Japan 42 1.4k 0.3× 1.3k 0.3× 1.3k 0.3× 2.2k 0.5× 716 0.3× 258 6.9k
Víctor Sánchez‐Margalet Spain 43 2.3k 0.5× 2.3k 0.5× 1.9k 0.4× 2.0k 0.5× 848 0.4× 215 7.6k
John‐Olov Jansson Sweden 41 1.3k 0.3× 1.8k 0.4× 2.3k 0.5× 1.9k 0.5× 414 0.2× 107 7.5k
Marisa Barone Italy 13 7.7k 1.6× 4.4k 1.0× 5.4k 1.2× 1.3k 0.3× 4.1k 1.9× 25 12.0k
Owen P. McGuinness United States 47 1.1k 0.2× 1.4k 0.3× 3.0k 0.7× 3.0k 0.7× 636 0.3× 142 8.5k

Countries citing papers authored by Alex M. DePaoli

Since Specialization
Citations

This map shows the geographic impact of Alex M. DePaoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex M. DePaoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex M. DePaoli more than expected).

Fields of papers citing papers by Alex M. DePaoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex M. DePaoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex M. DePaoli. The network helps show where Alex M. DePaoli may publish in the future.

Co-authorship network of co-authors of Alex M. DePaoli

This figure shows the co-authorship network connecting the top 25 collaborators of Alex M. DePaoli. A scholar is included among the top collaborators of Alex M. DePaoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex M. DePaoli. Alex M. DePaoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amjad, Waseem, Irina Shalaurova, Erwin Garcia, et al.. (2023). Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences. 24(17). 13332–13332. 6 indexed citations
2.
Jain, Rishi, H.J. Lenz, Wells A. Messersmith, et al.. (2021). 550P Initial results of a phase Ia/Ib study of NGM120, a first-in-class anti-GDNF family receptor alpha like (GFRAL) antibody in patients (pts) with advanced solid tumors. Annals of Oncology. 32. S610–S611. 4 indexed citations
3.
Wykoff, Charles C., Vrinda Hershberger, David Eichenbaum, et al.. (2021). Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results. American Journal of Ophthalmology. 235. 131–142. 20 indexed citations
4.
5.
Harrison, Stephen A., Guy Neff, Cynthia D. Guy, et al.. (2020). Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis. Gastroenterology. 160(1). 219–231.e1. 218 indexed citations breakdown →
6.
Zhou, Mei, Jian Luo, Michael Chen, et al.. (2017). Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15. Journal of Hepatology. 66(6). 1182–1192. 84 indexed citations
7.
Zhou, Mei, Xueyan Wang, Phùng Văn Trung, et al.. (2014). Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19. Cancer Research. 74(12). 3306–3316. 153 indexed citations
8.
DePaoli, Alex M., Linda S. Higgins, Robert R. Henry, Christos S. Mantzoros, & F. L. Dunn. (2014). Can a Selective PPARγ Modulator Improve Glycemic Control in Patients With Type 2 Diabetes With Fewer Side Effects Compared With Pioglitazone?. Diabetes Care. 37(7). 1918–1923. 55 indexed citations
9.
Matochik, John A., Edythe D. London, Bülent Okan Yıldız, et al.. (2005). Effect of Leptin Replacement on Brain Structure in Genetically Leptin-Deficient Adults. The Journal of Clinical Endocrinology & Metabolism. 90(5). 2851–2854. 145 indexed citations
10.
Welt, Corrine K., Jean L. Chan, John W. Bullen, et al.. (2004). Recombinant Human Leptin in Women with Hypothalamic Amenorrhea. New England Journal of Medicine. 351(10). 987–997. 639 indexed citations breakdown →
11.
Koutkia, Polyxeni, et al.. (2004). Relation of leptin pulse dynamics to fat distribution in HIV-infected patients. American Journal of Clinical Nutrition. 79(6). 1103–1109. 5 indexed citations
12.
Chan, Jean L., et al.. (2003). The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. Journal of Clinical Investigation. 111(9). 1409–1421. 468 indexed citations
13.
Petersen, Kitt Falk, Elif A Oral, Sylvie Dufour, et al.. (2002). Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. Journal of Clinical Investigation. 109(10). 1345–1350. 44 indexed citations
14.
Farooqi, I. Sadaf, Giuseppe Matarese, Graham M. Lord, et al.. (2002). Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation. 110(8). 1093–1103. 854 indexed citations breakdown →
15.
Farooqi, I. Sadaf, Giuseppe Matarese, Graham M. Lord, et al.. (2002). Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation. 110(8). 1093–1103. 108 indexed citations
16.
Petersen, Kitt Falk, Elif A Oral, Sylvie Dufour, et al.. (2002). Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. Journal of Clinical Investigation. 109(10). 1345–1350. 503 indexed citations breakdown →
17.
DePaoli, Alex M., et al.. (2000). Pharmacokinetics of Abarelix Following Administration of Abarelix Depot-F By Subcutaneous Injection in Women with Endometriosis-Associated Pain. Fertility and Sterility. 74(3). S185–S185. 1 indexed citations
18.
Musch, Mark W., Alex M. DePaoli, Crescence Bookstein, et al.. (1994). Glucocorticoids regulate Na+/H+ exchange expression and activity in region- and tissue-specific manner. American Journal of Physiology-Cell Physiology. 267(3). C796–C803. 69 indexed citations
19.
DePaoli, Alex M., et al.. (1994). G Protein-Activated Inwardly Rectifying Potassium Channel (GIRK1/KGA) mRNA in Adult Rat Heart and Brain by in Situ Hybridization Histochemistry. Molecular and Cellular Neuroscience. 5(6). 515–522. 35 indexed citations
20.
Bookstein, Crescence, Alex M. DePaoli, Yulei Xie, et al.. (1994). Na+/H+ exchangers, NHE-1 and NHE-3, of rat intestine. Expression and localization.. Journal of Clinical Investigation. 93(1). 106–113. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vishwa Deep Dixit Breakdown of academic impact, for papers by Masatomo Mori Breakdown of academic impact, for papers by Márta Korbonits Breakdown of academic impact, for papers by Michèle Guerre-Millo Breakdown of academic impact, for papers by Francesc Villarroya Breakdown of academic impact, for papers by Shuichi Okada Breakdown of academic impact, for papers by Víctor Sánchez‐Margalet Breakdown of academic impact, for papers by John‐Olov Jansson Breakdown of academic impact, for papers by Marisa Barone Breakdown of academic impact, for papers by Owen P. McGuinness
Rankless by CCL
2026